COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2023-2030
COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2023-2030
This report contains market size and forecasts of COVID-19 Vaccines & Therapeutics in Global, including the following market information:
Global COVID-19 Vaccines & Therapeutics Market Size 2024-2030, ($ millions)
The global COVID-19 Vaccines & Therapeutics market is projected to reach US$ million by 2029.
We surveyed the COVID-19 Vaccines & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Vaccines & Therapeutics Market, by Type, 2024-2030 ($ millions)
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Type
COVID-19 Vaccines
COVID-19 Therapeutics
Global COVID-19 Vaccines & Therapeutics Market, by Application, 2024-2030 ($ millions)
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Application
Children
Adult
Global COVID-19 Vaccines & Therapeutics Market, By Region and Country, 2024-2030 ($ Millions)
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Moderna Therapeutics
AstraZeneca
Janssen
Novavax
Gilead Sciences
Eli Lilly and Company
